SCHEMBL6137070

SCHEMBL6137070

Nc1ccc(O)c(-c2cccs2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
NPC1 O15118 4/20 0.46
MAPT P10636 4/20 0.46
RAB9A P51151 4/20 0.46
HSD17B10 Q99714 3/20 0.46
TP53 P04637 2/20 0.46
GFER P55789 1/20 0.46
ADORA2A P29274 4/20 0.44
ADORA1 P30542 3/20 0.44
TMIGD3 P0DMS9 2/20 0.44
PDE10A Q9Y233 1/20 0.44
RPS6KB2 Q9UBS0 1/20 0.43
GAA P10253 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GLA P06280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5704962 0.87 RPS6KB2 (0.44) KDM4ENPC1MAPTRAB9AHSD17B10
Hydrochloric Acid SCHEMBL5705099 0.85 RPS6KB2 (0.43) KDM4ENPC1MAPTRAB9AHSD17B10
SCHEMBL14027112 0.82 RPS6KB2 (0.53) KDM4ENPC1MAPTRAB9AHSD17B10
SCHEMBL33847 0.81 KCNH2 (0.53) KDM4ENPC1MAPTRAB9AHSD17B10
Hydrochloric Acid SCHEMBL6261430 0.79 KCNH2 (0.52) KDM4ENPC1MAPTRAB9AHSD17B10
SCHEMBL23991290 0.78 BACE1 (0.58) KDM4EMAPTHSD17B10TP53GFER
SCHEMBL6067845 0.78 RPS6KB2 (0.55) KDM4ENPC1MAPTRAB9AHSD17B10
SCHEMBL3530209 0.78 NPC1 (0.46) KDM4ENPC1MAPTRAB9AHSD17B10
SCHEMBL6764756 0.78 MAPT (0.45) KDM4ENPC1MAPTADORA2AADORA1
Hydrochloric Acid SCHEMBL23629396 0.77 BACE1 (0.56) KDM4EMAPTHSD17B10TP53GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1166749-B1 Composition and process for dyeing keratinic fibres WELLA AG (DE) 2005-10-12 EP claimed
EP-1158954-B1 MEANS AND METHOD FOR DYING KERATINIC FIBRES WELLA AG (DE) 2004-06-16 EP claimed
US-6592631-B2 Useful as developer compounds in oxidation dye compositions for keratin fibers. WELLA AG (DE) 2003-07-15 US claimed
US-6503282-B1 Composition for coloring keratin fibers based on a developer-coupler combination characterized in that it contains as the coupler 3-(2,4-diaminophenoxy)-1-propanol and as the developer ring and having general formula (I) WELLA AKTIENGESELLSCHAFT (DE) 2003-01-07 US claimed
EP-1166749-A2 Composition and process for dyeing keratinic fibres Wella Aktiengesellschaft (DE) 2002-01-02 EP claimed
US-20010054207-A1 p-aminophenol derivative compounds and dye compositions containing same WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) 2001-12-27 US claimed
EP-1158954-A1 MEANS AND METHOD FOR DYING KERATINIC FIBRES Wella Aktiengesellschaft (DE) 2001-12-05 EP claimed
EP-1153917-A1 p-Aminophenol derivatives and colorants containing them Wella Aktiengesellschaft (DE) 2001-11-14 EP claimed
WO-2001051019-A1 MEANS AND METHOD FOR DYING KERATINIC FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2001-07-19 WO claimed
EP-1166749-B1 Composition and process for dyeing keratinic fibres WELLA AG (DE) 2005-10-12 EP disclosed
EP-1153917-B1 p-Aminophenol derivatives and colorants containing them WELLA AG (DE) 2005-04-13 EP disclosed
EP-1158954-B1 MEANS AND METHOD FOR DYING KERATINIC FIBRES WELLA AG (DE) 2004-06-16 EP disclosed
US-6592631-B2 Useful as developer compounds in oxidation dye compositions for keratin fibers. WELLA AG (DE) 2003-07-15 US disclosed
US-6503282-B1 Composition for coloring keratin fibers based on a developer-coupler combination characterized in that it contains as the coupler 3-(2,4-diaminophenoxy)-1-propanol and as the developer ring and having general formula (I) WELLA AKTIENGESELLSCHAFT (DE) 2003-01-07 US disclosed
EP-1166749-A2 Composition and process for dyeing keratinic fibres Wella Aktiengesellschaft (DE) 2002-01-02 EP disclosed
US-20010054207-A1 p-aminophenol derivative compounds and dye compositions containing same WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) 2001-12-27 US disclosed
EP-1158954-A1 MEANS AND METHOD FOR DYING KERATINIC FIBRES Wella Aktiengesellschaft (DE) 2001-12-05 EP disclosed
EP-1153917-A1 p-Aminophenol derivatives and colorants containing them Wella Aktiengesellschaft (DE) 2001-11-14 EP disclosed
WO-2001051019-A1 MEANS AND METHOD FOR DYING KERATINIC FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2001-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010054207-A1 p-aminophenol derivative compounds and dye compositions containing same KRT18, AASDHPPT, S100P KDM4E 354/4885NPC1 4698/4885MAPT 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.